ConMed recalls 5.5mm GENESYS CrossFT Suture Anchors with possible incorrect patient implant cards, risking wrong device identification. Affected units have specific reference numbers.
“ConMed Suture Anchor Recall: Incorrect Implant Card Risk.” GovInfoNow, updated September 14, 2026. https://govinfonow.com/recall/697880-conmed-suture-anchor-recall-incorrect-implant-card-risk. Based on FDA recall #Z-3018-2026 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-3018-2026%22&limit=1).
ConMed Corporation voluntarily recalled CONMED Linvatec GENESYS CrossFT Suture Anchors on July 14, 2026, according to the FDA. The device may contain an incorrect patient implant card, resulting in incorrect identification and traceability.
Distribution: US Nationwide distribution in the state of TX
The hazard
The suture anchor may contain an incorrect patient implant card which may result in incorrect device identification and traceability.
Context
GovInfoNow's records show ConMed Corporation has 7 other recalls on record since 2017-06-19. Other recent recalls include the ConMed AirSeal 5mm Access Port (2026-05-14), the ConMed Foot Controlled Suction Coagulator (2022-11-18), and the ConMed Infinity Tray Custom Procedural Kit (2021-03-26). Other recent recalls of similar products include the Genesis Push-In Suture Anchor (2025-12-17), the Genesis Screw-In Anchor (2025-12-17), and the Boston Scientific OverStitch Suture Cinch (2026-07-14).
How to tell if you have this one
Check for the reference number CFBC-5502B and the model 5.5mm GENESYS CrossFT Suture Anchor. The product includes two #2 (5 metric) Hi-Fi Sutures and has a UDI:10845854042472.
Brand
ConMed
Category
Medical device
Based on the official FDA remedy
What to do — step by step
Check Device Identification
Verify the product's reference number and model to confirm it matches CFBC-5502B 5.5mm GENESYS CrossFT Suture Anchor.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “US Nationwide distribution in the state of TX.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 50 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4Added to GovInfoNow
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-3018-2026 (July 14, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-3018-2026 to see it in context.
Plain-language summary written by qwen3:4b on September 14, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.